Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like Agenda of the COMP meeting 17-19 January 2023 Agenda – PRAC draft agenda of meeting 25-28 October 2021 Agenda – Workshop on support for orphan medicines development
